BCL2-Interacting Killer (Apoptosis-Inducing) (BIK) (N-Term) Peptid
BIK
Reaktivität: Human
Wirt: Synthetic
BP, WB
Kurzübersicht für BCL2-Interacting Killer (Apoptosis-Inducing) (BIK) (N-Term) Peptid (ABIN5512171)
Target
BIK
(BCL2-Interacting Killer (Apoptosis-Inducing) (BIK))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- N-Term
-
Sequenz
- SEVRPLSRDI LMETLLYEQL LEPPTMEVLG MTDSEEDLDP MEDFDSLECM
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-BIK Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- BIK (BCL2-Interacting Killer (Apoptosis-Inducing) (BIK))
-
Hintergrund
-
The protein encoded by this gene shares a critical BH3 domain with other death-promoting proteins, such as BID, BAK, BAD and BAX, that is required for its pro-apoptotic activity, and for interaction with anti-apoptotic members of the BCL2 family, and viral survival-promoting proteins. Since the activity of this protein is suppressed in the presence of survival-promoting proteins, it is suggested as a likely target for anti-apoptotic proteins.
Alias Symbols: BIK,NBK,
Protein Size: 160 -
Gen-ID
- 638
-
NCBI Accession
- NP_001188
-
UniProt
- Q13323
Target
-
Sie sind hier:
